Interestingly, several independent studies suggest the upregulation of miR-155 in various brain regions of AD patients compared to controls as well as in the brain of transgenic mouse models of Aβ and tau pathologies [163,164]. The gene discussed is MAPT; the disease is Alzheimer disease.